Johnson & Johnson (NYSE: JNJ) recently reported its Q3 results, with revenues and earnings exceeding our estimates.

The NFL Draft is several months away but teams will have another opportunity to address roster issues over the next few weeks ...

Paul Johnson is standing down as director of the Institute for Fiscal Studies after more than a decade as one of the most ...

History will be in the air in New Orleans on Thursday night as the Saints honor Drew Brees during their game against the ...

People who voted to settle their baby power-related health claims against Johnson & Johnson should have their ballots thrown ...

Key Takeaways Johnson & Johnson shares advanced Tuesday after the pharmaceutical and medical device company posted better ...

Woody Johnson, to his credit (or his detriment?) is pulling out all the stops to get the Jets back on the right track, at a ...

Omarosa Manigault Newman, a former member of the Trump administration and contestant on his reality show "The Apprentice," ...

Johnson & Johnson's Q3 2024 results surpassed analyst expectations, reporting $2.42 EPS and $22.47 billion in sales. Updated ...

David Risinger, an analyst from Leerink Partners, maintained the Buy rating on Johnson & Johnson (JNJ – Research Report). The ...

A Springfield resident and local real estate entrepreneur, Evan Plotkin has just been awarded $15 million after a jury found ...

Cameron Grizzle-Johnson bags four tries in Barnstaple’s fierce 80-15 win, setting the stage for an explosive season with 11 ...